As sent to the press on October 30, 2026, word for word.

FOR IMMEDIATE RELEASE

Plaintiff in Nejmeh v. Theriva introduces four research sites to help investors check the facts on how small companies are financed

Mark Joseph Nejmeh, an SEC-registered large trader (Large Trader ID 71743954) and the plaintiff in Nejmeh v. Theriva Biologics, Inc., No. 3:26-cv-00705-ART-CSD (D. Nev.), says his lawsuit concerns one company, but he believes the pattern it describes runs through the financing of many small public companies: financiers hold up, and take away, the money that companies raised from retail shareholders. In his view, this is not a required way to fund a company; it is a game of acquiring wealth.

"My emphasis is the pattern of financiers that hold up and take away the important finances of the corporations funded by retail shareholders. This process they use is not a required method of funding; instead it's a game of acquiring wealth. I want to expose this pattern, and I have built tools that will do just that." - Mark Nejmeh

To help investors research the facts for themselves, Mr. Nejmeh introduces four sites, each built from companies' own SEC filings:

Mr. Nejmeh's filings in Nejmeh v. Theriva are posted unaltered at nejmehvstheriva.com. Every filing by both sides is public on PACER (Case No. 3:26-cv-00705-ART-CSD, U.S. District Court for the District of Nevada).

Contact: Mark Nejmeh · 732-995-3914 · [email protected]

The statements about financiers are Mr. Nejmeh's opinions. The allegations in Nejmeh v. Theriva are those of a pending lawsuit; no court has ruled on them. The sites present facts from public filings and opinions; nothing on them is investment advice.